SP
Insider selling
Steve Pakola sold $29K of REGENXBIO Inc. (RGNX) stock
Steve Pakola, Chief Medical Officer of REGENXBIO Inc. (RGNX), sold 2,161 shares of RGNX stock worth $29K, per an SEC Form 4 filed Jul 6, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 2, 2026, 4 days before it was made public.
RGNX has moved -44.1% since the trade date, from $13.28 to $7.43 (Oct 2, 2026 close).
- Traded
- Jul 2, 2026
- Disclosed
- Jul 6, 2026
- Filing delay
- 4 days
- Price since
- -44.1%
- Role
- Chief Medical Officer
- Source
- SEC Form 4
More RGNX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.